Gregory Gene Freitag - 24 May 2023 Form 4 Insider Report for ZyVersa Therapeutics, Inc. (ZVSA)

Reporting relationship: Director
Issuer ticker: ZVSA
Reported as of: 24 May 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Jul 2024, 21:35:08 UTC
Prior SEC filing: 24 May 2023
Next SEC filing: 05 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Peter Wolfe as Attorney-in-Fact for Gregory Freitag pursuant to Power of Attorney

Key filing fact

Gregory Gene Freitag filed Form 4 for ZyVersa Therapeutics, Inc. (ZVSA) on 18 Jul 2024.

Key facts

This page summarizes Gregory Gene Freitag's Form 4 filing for ZyVersa Therapeutics, Inc. (ZVSA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 18 Jul 2024, 21:35.

Change

Previous filing in this sequence was filed on 24 May 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZVSA transaction Derivative

Stock Options

Award

Transaction value: $0
Shares: +132
Change %
Price: $0.000000
Shares after: 132
Date: 24 May 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 132
Exercise price: $152.46
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The option disclosed on this Form 4 was not previously reported due to an administrative oversight.

Footnote F2

Share and dollar amounts give effect to the issuer's 1-for-35 reverse stock split effectuated on December 4, 2023, and 1-for-10 reverse stock split effectuated on April 25, 2024.

Footnote F3

The option vests annually in three equal installments commencing on May 24, 2024.

SEC remarks

Exhibit 24.1 - Power of Attorney